WCM
BIIB icon

Whitener Capital Management’s Biogen BIIB Stock Holding History

Whitener Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-570
Closed -$132K – 168
2019
Q3 		$132K Hold
570
– – 0.07% 148
2019
Q2 		$133K Sell
570
-100
-15% -$23.1K 0.08% 150
2019
Q1 		$158K Sell
670
-20
-3% -$6.3K 0.1% 129
2018
Q4 		$207K Buy
690
+50
+8% +$16K 0.15% 114
2018
Q3 		$226K Buy
+640
New +$220K 0.15% 115
2018
Q2 		– Sell
-660
Closed -$180K – 148
2018
Q1 		$180K Hold
660
– – 0.14% 123
2017
Q4 		$210K Buy
+660
New +$212K 0.18% 109

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitener Capital Management's BIIB Position: Q4 2019 in Review

Whitener Capital Management sold out of Biogen (BIIB) in Q4 2019, closing a stake of 570 shares — an estimated $132K sold.

Whitener Capital Management first reported a position in BIIB in Q4 2017 and held it in 7 quarters. The position peaked at $226K in Q3 2018. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Whitener Capital Management reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Whitener Capital Management sold 570 Biogen shares in Q4 2019, an estimated $132K.
  • Whitener Capital Management first reported a position in Biogen in Q4 2017 and held it in 7 quarters.
  • Whitener Capital Management's Biogen position peaked at $226K in Q3 2018.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Whitener Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.